doxorubicin hydrochloride,brentuximab,dacarbazine,filgrastim,pegfilgrastim,nivolumab,vinblastine sulfate
seagen,amgen,bms
['s1826']
excellent review by md. herrera at #asco23 about the swog s1826, that is the largest hl study in nctn history, being a key step towards harmonizing the pediatric and adult treatment of as hl , concluding that n-avd improved pfs vs bv-avd in pts with as hl 
Medical Oncologist at Centro Oncológico Integral, Hospital Ángeles Puebla. Cancer treatment must be personalized to the individual needs of the patient.